A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
Clinical trial NCT00441116 · COMPLETED
Trial details
- NCT number
- NCT00441116
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-15
- Primary completion
- 2008-01-21
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.